{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:46:47Z","timestamp":1790398007011,"version":"4.1.0"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3201\/eid2306.161884","type":"journal-article","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T13:25:04Z","timestamp":1496669104000},"source":"Crossref","is-referenced-by-count":16,"title":["Sporadic Creutzfeldt-Jakob Disease in 2 Plasma Product Recipients, United Kingdom"],"prefix":"10.3201","volume":"23","author":[{"given":"Patrick","family":"Urwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Thanigaikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Ironside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Molesworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Llewelyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Will","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1126\/science.1675487","article-title":"Molecular biology of prion diseases.","volume":"252","author":"Prusiner","year":"1991","journal-title":"Science"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1537-2995.2008.02056.x","article-title":"Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.","volume":"49","author":"Dorsey","year":"2009","journal-title":"Transfusion"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/vox.12371","article-title":"Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.","volume":"110","author":"Urwin","year":"2016","journal-title":"Vox Sang"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-4","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa030351","article-title":"Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease.","volume":"349","author":"Glatzel","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3201\/eid2001.130353","article-title":"Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease.","volume":"20","author":"Douet","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-6","unstructured":"European Medicines Agency. CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products. London, 23 June 2011 [cited 2015 May 1]. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Position_statement\/2011\/06\/WC500108071.pdf"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/bmj.315.7105.389","article-title":"Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96.","volume":"315","author":"Cousens","year":"1997","journal-title":"BMJ"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-8","first-page":"1285","article-title":"Creutzfeldt-Jakob disease: a collaborative study in Europe.","volume":"57","author":"Wientjens","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.23589","article-title":"Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease.","volume":"72","author":"McGuire","year":"2012","journal-title":"Ann Neurol"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0002-9440(10)63105-7","article-title":"Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study.","volume":"164","author":"Head","year":"2004","journal-title":"Am J Pathol"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/ana.20127","article-title":"Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.","volume":"55","author":"Head","year":"2004","journal-title":"Ann Neurol"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-12","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/j.1537-2995.2010.03004.x","article-title":"Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases.","volume":"51","author":"Puopolo","year":"2011","journal-title":"Transfusion"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-13","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1111\/j.1537-2995.2011.03198.x","article-title":"Sporadic Creutzfeldt-Jakob disease and risk of blood transfusion in the United Kingdom.","volume":"51","author":"Molesworth","year":"2011","journal-title":"Transfusion"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-14","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"key":"key-10.3201\/eid2306.161884-201706050924-R-2-15","doi-asserted-by":"publisher","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","article-title":"Quantifying prion disease penetrance using large population control cohorts.","volume":"8","author":"Minikel","year":"2016","journal-title":"Sci Transl Med"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/23\/6\/16-1884_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:32:07Z","timestamp":1732923127000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/23\/6\/16-1884_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2306.161884","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}